4568 (4568) News
Track canonical SquawkNews coverage tagged to 4568, 4568. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
AstraZeneca and Daiichi Sankyo win new EU approval for breast cancer drug
AstraZeneca and Daiichi Sankyo received a new EU approval for a breast cancer drug.
EQUITY | Sep 01, 2026, 07:02 AM UTC
M
EU approves Enhertu plus pertuzumab for HER2+ metastatic breast cancer
The EU has approved Enhertu plus pertuzumab as a new first-line regimen for patients with HER2-positive metastatic breast cancer.
EQUITY | Sep 01, 2026, 06:30 AM UTC
L
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk
EQUITY | Aug 28, 2026, 08:00 AM UTC
M
DS1025 enters clinical development for advanced solid tumors
DS1025 is entering clinical development for patients with advanced solid tumors as a CD25-directed ADC.
EQUITY | Aug 27, 2026, 11:00 AM UTC